Award details

Further development of an AAV vector production system exploiting novel AAV/HSV hybrids

ReferenceE20016
Principal Investigator / Supervisor Dr R Coffin
Co-Investigators /
Co-Supervisors
Dr Matthew Booth, Professor Adrian Thrasher
Institution University College London
DepartmentImmunology and Molecular Pathology
Funding typeResearch
Value (£) 160,357
StatusCompleted
TypeResearch Grant
Start date 01/10/2003
End date 30/09/2006
Duration36 months

Abstract

This project aims to further develop production technology for AAV vectors through the use of HSV/AAV hybrids rather than the more commonly used adenovirus. This builds on previous BBSRC funded work where considerable progress was made. Clinical trials using AAV vectors are promising in e.g. haemophilia, but effective and scalable production technology is lacking. The aim of the project is to develop a robust and scalable production system not requiring transfection as is currently the case. We have generated HSV-based production systems overcoming various technical hurdles which now require further optimisation and development before up-scaling as required if HSV produced AAV vectors are to be used in pre-clinical and clinical studies.

Summary

unavailable
Committee Closed Committee - Engineering & Biological Systems (EBS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative LINK: Engineering & Biological System Committee (EBL) [2000-2003]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file